What is the recommended oral dosing regimen for fluconazole (antifungal medication) in treating severe intertrigo of fungal origin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

For severe fungal intertrigo, fluconazole is typically prescribed at a dose of 150-200 mg orally once daily for 7-14 days, as supported by the most recent and highest quality study available 1.

Treatment Overview

The treatment of severe fungal intertrigo with fluconazole involves oral administration, with the option to extend treatment to 2-4 weeks in severe cases or if the infection is slow to respond.

  • The initial loading dose may be twice the daily dose (300-400 mg) on the first day to achieve therapeutic levels more quickly.
  • Fluconazole works by inhibiting fungal cytochrome P450-dependent enzymes, preventing the synthesis of ergosterol, an essential component of fungal cell membranes.
  • This leads to increased cell permeability and ultimately cell death.

Administration and Precautions

  • Patients should take the medication with or without food at approximately the same time each day.
  • Dose adjustments may be necessary for patients with renal impairment, as fluconazole is primarily eliminated unchanged in the urine 2.
  • Common side effects include nausea, headache, and abdominal pain.
  • Patients should be advised to complete the full course of treatment even if symptoms improve before completion to prevent recurrence and development of resistance.

Concurrent Treatment

  • Concurrent topical antifungal treatment may also be beneficial to accelerate symptom relief.
  • The choice of concurrent treatment should be based on the specific fungal infection and the patient's overall health status.

Evidence Summary

The recommended dosing regimen is based on the study by 1, which reviewed the effectiveness of oral antifungal agents, including fluconazole, in the treatment of common superficial fungal infections of the skin.

  • Other studies, such as 2, 3, 4, and 5, also support the use of fluconazole in the treatment of fungal infections, but the study by 1 provides the most recent and comprehensive guidance on the treatment of severe fungal intertrigo.

References

Research

Oral therapy of common superficial fungal infections of the skin.

Journal of the American Academy of Dermatology, 1999

Research

Fluconazole: a new triazole antifungal agent.

DICP : the annals of pharmacotherapy, 1990

Research

Fluconazole in the treatment of tinea corporis and tinea cruris.

Dermatology (Basel, Switzerland), 1998

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.